{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:33:10Z","timestamp":1791181990331,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.iac.2006.05.008","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T10:09:23Z","timestamp":1168423763000},"page":"535-547","source":"Crossref","is-referenced-by-count":51,"title":["Flow Cytometric Analysis of Normal and Neoplastic Mast Cells: Role in Diagnosis and Follow-Up of Mast Cell Disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Luis","family":"Escribano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres C.","family":"Garcia Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2006.05.008_bib1","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.4049\/jimmunol.146.5.1410","article-title":"Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells","volume":"146","author":"Kirshenbaum","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.iac.2006.05.008_bib2","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4049\/jimmunol.148.3.772","article-title":"Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells","volume":"148","author":"Kirshenbaum","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.iac.2006.05.008_bib3","first-page":"1147","article-title":"Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells","volume":"22","author":"Rottem","year":"1994","journal-title":"Exp Hematol"},{"key":"10.1016\/j.iac.2006.05.008_bib4","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood.V84.8.2489.2489","article-title":"Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+\/FceRI\u2212 cell population","volume":"84","author":"Rottem","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.iac.2006.05.008_bib5","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood.V94.7.2333.419k30_2333_2342","article-title":"Demonstration that human mast cells arise from a progenitor cell population that is CD34+, c-ki+, and expresses aminopeptidase N (CD13)","volume":"94","author":"Kirshenbaum","year":"1999","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.iac.2006.05.008_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10428199409052682","article-title":"Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry","volume":"13","author":"Orfao","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.iac.2006.05.008_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2141.1995.tb03309.x","article-title":"Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML","volume":"89","author":"Macedo","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.iac.2006.05.008_bib8","first-page":"1493","article-title":"Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples. Identification and enumeration","volume":"149","author":"Orfao","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.iac.2006.05.008_bib9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2141.1999.01572.x","article-title":"The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease","volume":"106","author":"Diaz-Agustin","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.iac.2006.05.008_bib10","series-title":"Current protocols in cytometry","article-title":"Flow cytometry immunophenotypic analysis of human mast cells","author":"Escribano","year":"2000"},{"key":"10.1016\/j.iac.2006.05.008_bib11","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood.V73.7.1778.1778","article-title":"Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes","volume":"73","author":"Valent","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.iac.2006.05.008_bib12","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1182\/blood.V79.3.708.708","article-title":"Immunophenotyping and functional analysis of purified human uterine mast cells","volume":"79","author":"Guo","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.iac.2006.05.008_bib13","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1182\/blood.V84.11.3876.bloodjournal84113876","article-title":"The human cardiac mast cell: localization, isolation, phenotype, and functional characterization","volume":"84","author":"Sperr","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.iac.2006.05.008_bib14","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1182\/blood.V84.9.2954.2954","article-title":"Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation","volume":"84","author":"F\u00f6dinger","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.iac.2006.05.008_bib15","first-page":"142","article-title":"Receptors for IgE on mast cells and basophils","volume":"34","author":"Froese","year":"1984","journal-title":"Prog Allergy"},{"key":"10.1016\/j.iac.2006.05.008_bib16","first-page":"188","article-title":"Activation of mast cells for mediator release through IgE receptors","volume":"34","author":"Ishizaka","year":"1984","journal-title":"Prog Allergy"},{"key":"10.1016\/j.iac.2006.05.008_bib17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000235115","article-title":"Further characterization of surface membrane structures expressed on human basophils and mast cells","volume":"91","author":"Valent","year":"1990","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.iac.2006.05.008_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0065-2776(08)60879-2","article-title":"Cell surface structures on human basophils and mast cells: biochemical and functional characterization","volume":"52","author":"Valent","year":"1992","journal-title":"Adv Immunol"},{"key":"10.1016\/j.iac.2006.05.008_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cyto.990140316","article-title":"Flow cytometric evaluation of human basophils","volume":"14","author":"Gane","year":"1993","journal-title":"Cytometry"},{"key":"10.1016\/j.iac.2006.05.008_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood.V78.1.30.30","article-title":"Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow","volume":"78","author":"Ashman","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.iac.2006.05.008_bib21","first-page":"854","article-title":"The product of the proto-oncogene c-kit is a human bone marrow surface antigen of hemopoietic precursor cell which is expressed on a subset of acute non-lymphoblastic leukemic cells","volume":"5","author":"Buhring","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/j.iac.2006.05.008_bib22","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood.V78.6.1403.1403","article-title":"Isolation of c-kit receptor expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile","volume":"78","author":"Papayannopoulou","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.iac.2006.05.008_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/stem.5530100403","article-title":"The c-kit proto-oncogene in normal and malignant human hematopoiesis","volume":"10","author":"Ratajezac","year":"1992","journal-title":"Int J Cell Cloning"},{"key":"10.1016\/j.iac.2006.05.008_bib24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1084\/jem.178.3.1079","article-title":"Expression of a functional c-kit receptor on a subset of natural killer cells","volume":"178","author":"Matos","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.iac.2006.05.008_bib25","first-page":"1025","article-title":"The c-kit proto-oncogene receptor is expressed on a subset of human CD3\u2212CD4\u2212CD8\u2212 (triple-negative) thymocytes","volume":"22","author":"DeCastro","year":"1994","journal-title":"Exp Hematol"},{"key":"10.1016\/j.iac.2006.05.008_bib26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood.V92.2.596","article-title":"The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL)","volume":"92","author":"Bene","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.iac.2006.05.008_bib27","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2141.1994.tb05115.x","article-title":"Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells","volume":"88","author":"Lemoli","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.iac.2006.05.008_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2141.1996.tb08993.x","article-title":"Expression of the CD117 antigen (C-Kit) on normal and myelomatous plasma cells","volume":"95","author":"Ocqueteau","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.iac.2006.05.008_bib29","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1182\/blood.V99.5.1853","article-title":"Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome","volume":"99","author":"San Miguel","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.iac.2006.05.008_bib30","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1158\/1078-0432.CCR-04-1489","article-title":"Genetic abnormalities and patterns of antigenic expression in multiple myeloma","volume":"11","author":"Mateo","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.iac.2006.05.008_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jlb.48.2.138","article-title":"Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells","volume":"48","author":"Terstappen","year":"1990","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.iac.2006.05.008_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2141.2003.04055.x","article-title":"Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis","volume":"120","author":"Nu\u00f1ez","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.iac.2006.05.008_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1155\/1998\/341340","article-title":"Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples","volume":"16","author":"Escribano","year":"1998","journal-title":"Anal Cell Pathol"},{"key":"10.1016\/j.iac.2006.05.008_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/10428199909145725","article-title":"Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults","volume":"35","author":"Escribano","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.iac.2006.05.008_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0145-2126(01)00050-9","article-title":"Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis","volume":"25","author":"Escribano","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.iac.2006.05.008_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000048183","article-title":"Abnormal expression of CD antigens in mastocytosis","volume":"127","author":"Escribano","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2006.05.008_bib37","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1365-2141.1995.tb05417.x","article-title":"Expression of lymphoid-associated antigens in mast cells: report of a case of systemic mast cell disease","volume":"91","author":"Escribano","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.iac.2006.05.008_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0320(19970415)30:2<98::AID-CYTO4>3.0.CO;2-9","article-title":"Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia","volume":"30","author":"Escribano","year":"1997","journal-title":"Cytometry"},{"key":"10.1016\/j.iac.2006.05.008_bib39","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications","volume":"91","author":"Escribano","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.iac.2006.05.008_bib40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1468-3083.2003.00603.x","article-title":"Indolent systemic mast cell disease: immunophenotypic characterization of bone marrow mast cells by flow cytometry","volume":"17","author":"Bodni","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.iac.2006.05.008_bib41","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.leukres.2003.10.035","article-title":"Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients","volume":"28","author":"Pardanani","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.iac.2006.05.008_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10072","article-title":"Immunophenotypic analysis of mast cells in mastocytosis: when and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA)","volume":"58B","author":"Escribano","year":"2004","journal-title":"Cytometry"},{"key":"10.1016\/j.iac.2006.05.008_bib43","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-Kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2003","journal-title":"Blood"},{"issue":"Suppl","key":"10.1016\/j.iac.2006.05.008_bib44","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1016\/j.jaci.2004.01.683","article-title":"Well-differentiated systemic mastocytosis: a new disease variant with mature mast cell phenotype and lack of codon 816 c-Kit mutations","volume":"113","author":"Akin","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2006.05.008_bib45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1097-0320(19981015)34:5<223::AID-CYTO3>3.0.CO;2-B","article-title":"Human bone marrow mast cells from indolent systemic mast cell disease constitutively express increased amounts of the CD63 protein on their surface","volume":"34","author":"Escribano","year":"1998","journal-title":"Cytometry"},{"key":"10.1016\/j.iac.2006.05.008_bib46","first-page":"1708","article-title":"Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions","volume":"45","author":"Orfao","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.iac.2006.05.008_bib47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1470-2045(00)00418-6","article-title":"Minimal residual disease in leukaemia patients","volume":"2","author":"Szczepanski","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.iac.2006.05.008_bib48","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/sj.leu.2402584","article-title":"Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation","volume":"16","author":"Sanchez","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.iac.2006.05.008_bib49","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/sj.leu.2401824","article-title":"Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6\/AML1 ALLs identification","volume":"14","author":"De Zen","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.iac.2006.05.008_bib50","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.leu.2402060","article-title":"Adult precursor B-ALL with BCR\/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression","volume":"15","author":"Tabernero","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.iac.2006.05.008_bib51","first-page":"405","article-title":"The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements","volume":"84","author":"Orfao","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.iac.2006.05.008_bib52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000085563","article-title":"Clonality and molecular pathogenesis of mastocytosis","volume":"114","author":"Akin","year":"2005","journal-title":"Acta Haematol"},{"key":"10.1016\/j.iac.2006.05.008_bib53","unstructured":"Valent P, Horny H-P, Li CY, et al. Mastocytosis (mast cell disease). In: Jaffe ES, Harris NL, Stein H, et al, editors. World Health Organization (WHO) classification of tumours. Pathology and genetics. Tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001. p. 291\u2013302."},{"key":"10.1016\/j.iac.2006.05.008_bib54","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.iac.2006.05.008_bib55","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/1042819021000037967","article-title":"Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL","volume":"44","author":"Noack","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.iac.2006.05.008_bib56","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0145-2126(02)00073-5","article-title":"Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis. Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma","volume":"26","author":"Escribano","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.iac.2006.05.008_bib57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaci.2004.02.042","article-title":"Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis","volume":"114","author":"Escribano","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2006.05.008_bib58","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.leu.2403329","article-title":"Immunophenotypic normalization of aberrant mast cells accompanies histological remission in imatinib-treated patients with eosinophilia-associated mastocytosis","volume":"18","author":"Elliott","year":"2004","journal-title":"Leukemia"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856106000555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856106000555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T05:49:02Z","timestamp":1683697742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856106000555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0889856106000555"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2006.05.008","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}